Category
Drug Product CDMOs
Compare drug product CDMOs for formulation development, solid oral dosage, sterile injectables, and specialty dosage forms. Filter by dosage type, scale, and certifications.
1365 companies listed
About Drug Product Manufacturing
Drug product manufacturing transforms active pharmaceutical ingredients into the finished dosage forms patients use. This includes solid oral dosage (tablets, capsules), sterile injectables (vials, pre-filled syringes), semi-solids (creams, gels), and specialty forms (transdermal patches, inhalers, implants).
Formulation development is where science meets engineering. A CDMO's formulation team determines bioavailability, stability, and manufacturability. For poorly soluble compounds, techniques like spray drying, hot melt extrusion, and nano-milling can be the difference between a viable product and a failed program. Ask for specific experience with your compound class.
What scale do you need? Clinical-phase drug product often runs in batches of 5,000-50,000 units. Commercial scale might mean millions of units per month. Few CDMOs cover the full range efficiently. Match your current and projected volumes to a CDMO with the right equipment and batch size flexibility.
Companies (1365)
Nitto Avecia (incl. Nitto Avecia Pharma Services)
United States
Nitto Avecia (part of Nitto Denko Corporation) is a US-based CDMO specializing in oligonucleotide drug substance manufacturing with over 25 years of experience. The company provides comprehensive services from preclinical manufacturing (OliGrow service) through commercial scale, including analytical development, process development, drug substance manufacturing, process performance qualification (PPQ), quality control, and stability testing. It achieved ANVISA GMP certification in 2025.
Formulation DevelopmentAnalytical ServicesMethod Development & Validation
N
Northeast Pharmaceutical Group Co., Ltd. (NEPG)
China
Northeast Pharmaceutical Group (NEPG) is a large-scale comprehensive pharmaceutical enterprise in Shenyang, China, under Fangda Group. The company operates three major business segments: chemical synthetic API and bio-fermentation API, western medicinal preparations and micro-ecological preparations, and medical business distribution. NEPG is China's first Vitamin C producer and the inventor of the two-step fermentation technology for VC production, with the world's largest Piracetam production capacity.
Frequently Asked Questions
What is drug product manufacturing?+
Drug product manufacturing converts APIs into final dosage forms for patients. The process includes formulation development (choosing excipients, optimizing bioavailability), process development (granulation, compression, coating, filling), analytical method development, stability testing, and scale-up to commercial volumes. It also covers packaging and labeling.
What dosage forms can drug product CDMOs produce?+
Common dosage forms include tablets (immediate-release, modified-release, orally disintegrating), capsules (hard gelatin, HPMC, softgel), sterile injectables (lyophilized, liquid), semi-solids (creams, ointments, gels), liquids (solutions, suspensions, syrups), and specialty forms (transdermal patches, inhalers, suppositories, implants). Most CDMOs specialize in 2-3 dosage forms rather than offering all.
Need help finding the right CDMO?
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
